- Home
- FENC vs EOD Comparison
FENC vs EOD Comparison
Compare FENC & EOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- EOD
- Stock Information
- Founded
- FENC 1996
- EOD 2007
- Country
- FENC United States
- EOD United States
- Employees
- FENC N/A
- EOD N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- EOD Investment Managers
- Sector
- FENC Health Care
- EOD Finance
- Exchange
- FENC Nasdaq
- EOD Nasdaq
- Market Cap
- FENC 234.9M
- EOD 245.9M
- IPO Year
- FENC 2001
- EOD N/A
- Fundamental
- Price
- FENC $8.01
- EOD $5.67
- Analyst Decision
- FENC Strong Buy
- EOD
- Analyst Count
- FENC 2
- EOD 0
- Target Price
- FENC $13.50
- EOD N/A
- AVG Volume (30 Days)
- FENC 111.8K
- EOD 118.1K
- Earning Date
- FENC 11-13-2025
- EOD 01-01-0001
- Dividend Yield
- FENC N/A
- EOD 9.28%
- EPS Growth
- FENC N/A
- EOD N/A
- EPS
- FENC N/A
- EOD N/A
- Revenue
- FENC $38,790,000.00
- EOD N/A
- Revenue This Year
- FENC N/A
- EOD N/A
- Revenue Next Year
- FENC $64.79
- EOD N/A
- P/E Ratio
- FENC N/A
- EOD N/A
- Revenue Growth
- FENC N/A
- EOD N/A
- 52 Week Low
- FENC $3.96
- EOD $3.73
- 52 Week High
- FENC $9.92
- EOD $4.71
- Technical
- Relative Strength Index (RSI)
- FENC 41.09
- EOD 46.11
- Support Level
- FENC $7.53
- EOD $5.63
- Resistance Level
- FENC $8.42
- EOD $5.83
- Average True Range (ATR)
- FENC 0.47
- EOD 0.07
- MACD
- FENC -0.04
- EOD -0.01
- Stochastic Oscillator
- FENC 20.86
- EOD 35.00
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest
Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.